title: Time to demand dosimetry for molecular radiotherapy?
abstract: Molecular radiotherapy (MRT) has been used clinically for around 75 years. Despite this long history of clinical use, there is no established dosimetry practice for calculating the absorbed dose delivered to tumour targets or to organs at risk. As a result, treatment protocols have often evolved based on experience with relatively small numbers of patients, each receiving a similar administered activity but, potentially, widely varying doses. This is in stark contrast to modern external-beam radiotherapy practice. This commentary describes some of the barriers to MRT dosimetry and gives some opinions on the way forward.
authors.affiliation: 1 Department of Oncology, University of Oxford, Oxford, UK.
authors.forename: D R
authors.initials: DR
authors.lastname: McGowan
authors.forename: M J
authors.initials: MJ
authors.lastname: Guy
mesh_terms: D002985:Clinical Protocols; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D011874:Radiometry / Q000379:methods*; D011879:Radiotherapy Dosage; D013997:Time Factors